Rel-Cis-6-(4-(1-(4-hydroxycyclohexyl)-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one;OPC-13217;4-CIS-HYDROXY CILOSTAZOL;OPC-13217, 4;OPC-13217 (cis): 3,4-dihydro-6-[4-[1-(trans-4-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-2-(1H)-Quinolinone;OPC-13217 : 3,4-dihydro-6-[4-[1-(trans-4-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-2-(1H)-Quinolinone;4-cis-Hydroxy Cilostazol (OPC-13217);
4-cis-Hydroxy Cilostazol (OPC-13217) is a fully characterized chemical compound used as a reference standard of API Cilostazol. The standard offered is compliant with regulatory guidelines. 4-cis-Hydroxy Cilostazol (OPC-13217) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 87153-06-08
Related products
Cilostazol USP Related Compound B-d11 (Cilostazol Metabolite (OPC-13015)-d11)
M.F.
M.W. 378.52
CAT# AR-C07585
CAS# NA
